Objective: The role of the central melanocortin system in the development of obesity has been extensively studied. Singlenucleotide polymorphisms (SNPs) within several candidate genes have been associated with food intake and obesity-related phenotypes; however, few of these associations have been replicated. SNPs in the agouti-related protein (AGRP) gene coding (Ala67Thr, 199G/A) and promoter (À38C/T) have been reported to be associated with body mass index (BMI), fat mass (FM) and percent body fat, in populations of European and African descent. In this study, we evaluated the association between the functional AGRP À38C/T promoter SNP and weight-related traits, namely BMI, FM and fat-free mass (FFM), as well as diabetes status. Design: An association study of the AGRP À38C/T SNP and indices of obesity and diabetes status. Subjects: A well-characterized population of 538 West Africans from Ghana and Nigeria recruited in the AADM (Africa America Diabetes Mellitus) study (mean age 52 years, 41.3% males, 71% diabetic). Measurements: Genotyping of the AGRP À38C/T SNP, BMI, FM, FFM and fasting plasma glucose. Results: Women carrying two copies of the variant T allele had significantly lower BMI (OR ¼ 0.47; 95% CI,. Also, men with at least one copy of the variant T allele were over two times less likely to be diabetic than other men (OR ¼ 0.44; 95% CI, 0.22-0.89). Conclusion: Our results replicate previous findings and implicate the AGRP À38C/T SNP in the regulation of body weight in West Africans.
Introduction
Obesity [MIM 601665 ] is a complex metabolic disorder that results from a sustained imbalance between food intake and energy expenditure. 1 It is a multifactorial disease that involves additive and interactive effects of a number of genetic variants as well as environmental factors. 2 It has been suggested that obesity and its related phenotypes, such as body mass index (BMI), fat mass (FM) and fat-free mass (FFM), are most likely oligogenic traits, and therefore are influenced by a few genes with measurable effects expressed on a polygenic background. 3 11 Activation of MC3R and MC4R prevents overweight development by reducing food intake, while antagonistic action on them alters their effect on food consumption and could lead to hyperphagia and obesity. 12 In addition, the melanocortin axis is also implicated in glucose homeostasis and insulin secretion and resistance. 13 AGRP is a 132 amino-acid protein, partially homologous to the agouti protein, whose expression is downregulated by leptin 14, 15 and insulin, 16 and upregulated by fasting.
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Overexpression of the agouti protein or AGRP in transgenic mice results in severe obesity, increased body length, hyperplasia, hyperglycemia and hyperinsulinemia. 18, 19 Additionally, leptin deficient (ob/ob) and leptin receptor deficient (db/db) mice exhibit increased hypothalamic AGRP mRNA levels. 15, 20 In humans, Katsuki et al. 21 reported significantly higher serum levels of AGRP in obese men than in nonobese men, and a correlation of AGRP plasma concentration with BMI, body fat weight and other parameters of obesity. The AGRP gene is located on chromosome 16q22, is composed of four exons and expresses two alternatively spliced transcripts, one in the arcuate nucleus of the hypothalamus and the other in peripheral tissues such as the adrenal gland, testes and the lungs. 15, 20 Based on its function as a modulator of the melanocortin pathway, it has been suggested that single-nucleotide polymorphisms (SNPs) in this gene may contribute to the obese/lean phenotype. Vink et al. 22 identified an SNP in the third exon of the gene (c.199G/A), which leads to a substitution of an alanine by a threonine residue at position 67 (Ala67Thr 
Research methods and procedures
Study subjects Individuals with and without T2DM were enrolled in five centers located in Ghana (Accra and Kumasi) and Nigeria (Enugu, Ibadan and Lagos) for a population-based study of the genetic epidemiology of T2DM. 25 The Institutional
Review Boards of the AADM study centers approved the study and written consent was obtained from all subjects. Diabetes cases were between 24 and 80 years of age. The mean duration of diabetes was approximately 7 years. Genotype and phenotype data were available on 538 participants (381 diabetes cases and 157 healthy controls). Demographic and anthropometric information on the study participants is shown in Table 1 .
Obesity and diabetes phenotypes
For a detailed description of ascertainment criteria and sample collection, see Rotimi et al. 25 Briefly, the diagnosis of diabetes was based on the criteria determined by the American Diabetes Association of a fasting plasma glucose concentration X126 mg/dl or a 2-h postload value in the oral glucose tolerance test X200 mg/dl on more than one occasion. 25 Control subjects exhibited a fasting plasma glucose concentration o110 mg/dl or a 2-h postload o140 mg/dl. Putative type 1 diabetes cases were excluded by the detection of autoantibodies to glutamic acid decarboxylase and fasting C-peptide levels lower than 0.03 nmol/l. AGRP, obesity and diabetes in West Africans C Bonilla et al BMI was calculated from weight and height, while FM and FFM were determined using a single-frequency (50-kHz) bioelectric impedance analyzer (BIA) with tetrapolar placement of the electrodes. The BIA procedure has been previously validated against the deuterium dilution method in West African populations. 26 BMI was dichotomized based on the median value for the population as suggested by Pan et al. 27 In addition, two blood pressure readings were taken from every subject at each of sitting, standing and lying positions in that order. 25 Genotyping Genomic DNA was obtained from isolated lymphocytes using cell lysis, proteinase K-treatment, protein precipitation and DNA precipitation. Genotyping of the À38C/T polymorphism in the promoter region of AGRP gene was performed using Pyrosequencing (Pyrosequencing AB, Uppsala, Sweden). The primers for the polymorphism were designed from the published promoter sequence (NCBI accession # NM007316). A 126 bp fragment was amplified in a 50 ml PCR reaction containing 30 ng of genomic DNA, 20 pmol of forward unlabeled 5 0 -TGCCACATAGGGGTTG AGTAAG-3 0 primer and a reverse biotin-labeled primer (b indicates biotin) 5 0 -b-ATTTCCACAGGACAGGGACC-3 0 , 1 Â PCR buffer II (Perkin Elmer), 2 mM MgCl 2 , 0.2 mM dNTP and AmpliTaq Gold DNA polymerase. PCR reactions were performed for 50 cycles: denaturation at 951C for 30 s, annealing at 541C for 20 s and extension at 721C for 30 s.
Biotinylated single-stranded DNA fragments were generated by mixing the PCR product with streptavidin coated paramagnetic beads (Dynal beads M280, Dynal, Norway). An automated Pyrosequencing instrument (PSQ96) was used for genotyping. The reaction was carried out at 251C, and included a sequencing primer, 5 0 -AATTAAGCTTTCAGGG CC-3 0 . The DNA sequence was determined from the single peaks in the pyrogram using Pyrosequencing software. All samples were assayed in duplicate directly from genomic DNA, and the control DNAs in the assay included a known wild-type (CC), a heterozygous mutant (CT) and homozygous mutant (TT) variant samples. These control DNAs were confirmed by direct DNA sequencing using an ABI 377 DNA sequencer (ABI, Foster City, CA, USA).
Statistical analyses
Analysis of variance was used to test for differences in mean BMI between genotypes. The association of BMI and the AGRP polymorphism was evaluated using a general linear model. Logistic regression was also performed to test for association between dichotomously defined phenotypic variables (obesity-related traits and diabetes status) and the SNP genotype. Age, sex, BMI and/or diabetes status were included as covariates in both tests. We used the false discovery rate method (FDR) 28 implemented in the program Q-value to account for multiple testing.
We assessed the genotypic effect of the À38C/T variant under an additive (CC vs CT vs TT), dominant (CC vs CT/TT) or recessive model (CC/CT vs TT). We used contingency table analyses to compare genotype and allele frequencies between groups and to confirm that the observed genotype frequencies were in Hardy-Weinberg equilibrium. All analyses of association between genotype and phenotypes were conducted using the SPSS program (v.11).
Results
Allele and genotype frequencies of the À38C/T polymorphism for all participants, men and women are shown in Tables  2 and 3 . Allele frequencies for all groups were in HardyWeinberg equilibrium. The frequency of the T allele previously reported for Sierra Leone (35%) 12 was lower than what we observed in Ghana and Nigeria (42%) although the difference was not significant (P ¼ 0.072). Participants with T2DM were significantly older and had higher systolic blood pressure compared to the controls (data not shown). As expected, the body composition measurements were significantly different for men and women. Also, men were about 4 years older than women (Table 1) . No association was detected between the AGRP promoter SNP genotype and BMI, FFM and FM, using ANOVA with or without correction for multiple testing. Diabetes status was not associated with AGRP genotype either. However, when BMI was coded as a dichotomous variable using the median value of 26 kg/m 2 as a cutoff, 27 and genotype categories were CC/CT and TT, a significant association of BMI and AGRP genotype, adjusted for age and diabetes status, was found in females (OR ¼ 0.47; 95% CI, 0.25-0.87; P ¼ 0.017). Thus, women with at least one C allele were more than two times women who are homozygote for the T allele ( Figure 1 , Table 2 ). We selected a BMI of 26 kg/m 2 as the overweight threshold because it represents the population median, and it has been suggested that a median cutoff better predicts associated metabolic disorders such as hypertension, diabetes, hypercholesterolemia, hypertriglyceridemia and hyperuricemia. 27 In addition, we tested a BMI cutoff of 30 kg/m 2 for obesity and found a similar, although nonsignificant, trend among females (OR ¼ 0.62; 95% CI, 0.31-1.25; P ¼ 0.18). We did not observe any AGRP genotype effect on BMI among males. However, an association of genotype (coded as CC vs CT/TT) and T2DM status, controlling for age and BMI, was apparent among men (OR ¼ 0.44; 95% CI, 0.22-0.89; P ¼ 0.023), such that CC individuals were more than two times as likely to be affected with T2DM than heterozygote and homozygote TT individuals (Table 3) .
After adjustment for multiple testing using FDR only the association of AGRP and BMI in women showed a q-value lower than 0.1.
In addition, we stratified the dataset into two age groups, younger and older than 50 years, to test whether there was an association with late-onset obesity, as was reported by Argyropoulos et al. 24 Among older individuals we obtained very similar results (no association with genotype in the total sample and among males only), and an association of the TT genotype with lower BMI in females, although not as strongly significant as before (P ¼ 0.04), probably due to the smaller sample size. Among younger individuals, however, no significant associations were evident, not even in women (data not shown).
Discussion
In this study, we estimated the genotype and allele frequencies of a C/T polymorphism in the promoter region of the AGRP gene, 12 as well as its association with T2DM and obesity-related traits in multiple West African populations. Given that AGRP is part of the central melanocortin system and therefore involved in the regulation of energy homeostasis, AGRP SNPs may contribute to interindividual variation in weight-related phenotypes and disorders. The À38C/ T SNP was shown to occur mostly in populations of African descent, that is, Sierra Leoneans, Jamaicans and Gullahspeaking African Americans, at similar frequencies. 12 Our study confirms the presence of this variant in West Africa, namely in Ghana and Nigeria, at frequencies that are in agreement with those already reported. Additionally, we observed an association of the TT genotype with lower BMI in females and of the CC genotype with T2DM in males. Therefore, the T allele exhibited a recessive protective effect in females with respect to obesity and a dominant protective effect in males in relation to T2DM. Mayfield et al. 12 
obtained similar results in the Sierra
Leone population where individuals carrying the CC genotype showed higher BMI and were more likely to have diabetes than individuals with other genotypes. It is possible that environmental factors interact with the SNP since its effect was not detected among Jamaicans and the Gullahs. As we did not include in our models environmental variables that could have an impact on the phenotype such as socioeconomic background, diet or physical activity, we cannot completely rule out the action of a nongenetic factor that covaries with the genotype generating the same phenotypic outcome. Studies that take into account both genetic and nongenetic variables should be conducted in the future to address this issue. We also found that the effects of the À38C/T genotype are evident mostly in older women. A similar finding of association between a missense SNP in AGRP (c.199 G/A) and four different measures of adipocity, including BMI, FM, percent body fat and abdominal visceral fat, was described by Argyropoulos et al. 24 among the older generation (mean age ¼ 53 years) of the HERITAGE Family study. Functional studies have shown that the TT genotype at position À38 exhibits lower promoter activity and reduced binding affinity for transcription factors -especially of the E12/E47 type -which could subsequently alter the expression levels of the gene. 12, 29 A reduction in AGRP expression might lead to a diminished appetite and a leaner phenotype due to the inability of the protein to completely inhibit MC3R and MC4R. In fact, a study by Argyropoulos et al. AGRP, obesity and diabetes in West Africans C Bonilla et al reported not only significantly lower BMI but also FM and percent body fat for TT subjects than for either CC or CT subjects in populations of African-descent from the US and Canada. The presence of T2DM in individuals with the higher promoter activity (CC) genotype may occur as a result of elevated food intake via a pathway involving neuropeptide Y (NPY)/AGRP neurons. 30 Insulin resistance and eventually diabetes could result from an increase in body adiposity. 31 However, it is also possible that AGRP, as part of the central melanocortin system, exerts its effects independently on glucose homeostasis besides its action on energy consumption and expenditure. Experiments conducted by Fan et al. 32 in mice suggest that a defect in the signaling of the central melanocortin pathway may cause an increase in the secretion of insulin, which could in turn lead to the desensitization of the insulin receptor. Noticeably in our sample the proportion of overweight (BMI426 kg/m 2 ) and obese (BMI430 kg/m 2 ) women is significantly greater than the proportion of men with the same characteristics (data not shown). It is possible that this difference influences our ability to detect a genotype effect.
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On the other hand, the gender differences observed in our study may be related to the differences in body composition and other measures of adiposity, including serum leptin levels. Among the factors influencing leptin plasma concentration are sex steroids, body fat patterning, energy expenditure and aerobic fitness, 33 which have been shown to vary between the sexes. Moreover, a recent study showed that AGRP is regulated by fasting in peripheral tissues as much as it is in the hypothalamus and that AGRP may directly regulate leptin transactivation. 34 Women have higher leptin levels than men after correction for adiposity, as well as more subcutaneous fat where expression of leptin mRNA is greater. 33 Putative binding sites for leptin Signal Transducers and Activators of Transcription (STATs) have been identified in the AGRP promoter at position À122/À114. 23 As the mutant À38T AGRP may be less effective in antagonizing MC4R to increase food consumption, the effect of higher concentrations of leptin on NPY and POMC neurons to reduce food intake may be more conspicuous in females. In contrast, lower levels of circulating leptin in men may not be sufficient to inhibit AGRP's action on MC4R leading to an elevated food intake and its potential consequences, such as the development of obesity and diabetes. Our findings, however, do not reveal a similar pattern of higher promoter activity (CC) genotype with higher BMI in males. Whether differences in leptin serum concentration really underlie the gender-specific results is something that should be further explored. Alternatively, the À38C/T promoter polymorphism could be linked to other variant(s) that directly influence the observed obese and diabetic phenotypic outcomes. A novel SNP has been recently found in the distal portion of the AGRP promoter (À3019G/A), that is in complete linkage disequilibrium with the À38C/T SNP. 35 The À3019A allele showed greater promoter activity in human and mice cell lines, as opposed to what has been seen for the À38T allele.
However, both alleles are associated with low body fatness. Thus, the concerted action of the distal and the proximal promoter SNPs on obesity phenotypes remains to be evaluated in more detail. A reference should be made to the procedure used to determine body composition in this study. The BIA methodology does not directly measure body composition. For that reason, it must be calibrated against other techniques and prediction equations are derived based on the correlation between both measurements. 36 In addition, since there are sex and population differences in body impedance, groupspecific reference data are needed in order to obtain meaningful results. 37, 38 BIA had been already validated for use in West African populations and was, therefore, deemed appropriate for our study 26 . However, as it relies on indirect estimates of body composition, it could be affected by errors in the criterion method selected for comparison besides the usual measurement errors. Another limitation of this study is also its partially low statistical power to detect a small effect of the genotype on each phenotype. Future studies with increased sample sizes will be necessary to verify and determine more precisely the effects of SNP À38C/T.
Polymorphisms in the AGRP gene appear to be involved in the development of body fatness in different populations (i.e. c.199G/A in European Americans, À38C/T in African Americans), but more genetic data and population samples are needed to confirm these results. For instance, it was recently shown that the c.199G/A polymorphism is not associated to the maintenance of body weight through variation in physical activity level in the Quebec Family Study. 39 Linkage to obesity phenotypes (BMI, FM and percent FM) has been identified on chromosomes 2, 4, 5, 40 while evidence of linkage to T2DM was observed on chromosomes 12, 19 and 20, 41 in the same West African sample. Since none of these genomic regions encompass the AGRP locus, it may only contribute small or moderate effects on the obesity/diabetes phenotype. It is also likely that interactions between multiple loci, such as those in the melanocortin pathway, which include AGRP, contribute to obesity-related phenotypes. Nevertheless, the replication of association of the CC genotype with T2DM in Ghana and Nigeria emphasizes the functionality of this SNP in West Africans. Alternatively, the TT genotype may provide a protective mechanism against T2DM for West Africans but only in their indigenous African environment. Our findings provide additional evidence regarding the role of AGRP in diseases such as obesity and diabetes that disproportionately affect populations of African descent.
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